ARCHIVES

Phase III Trial: Panobinostat Increases PFS by Four Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Brawley: CMS Got it Right in Lung Cancer Screening Decision

November 14, 2014

DCE Technical Support Contracts Recompetition Approved in Concept

November 22, 1991

FDA carries Action On Two Cancer Drugs Over To 1996

January 5, 1996

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005

In Brief: Forget Hew – It’s No HHS; Cancer Control Advisory Committee Meeting Set For Oct. 22

October 5, 1979

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

September 3, 2010